176 related articles for article (PubMed ID: 24413822)
1. Prevalence of amblyopia in children undergoing nasolacrimal duct irrigation and probing.
Ozgur OR; Sayman IB; Oral Y; Akmaz B
Indian J Ophthalmol; 2013 Dec; 61(12):698-700. PubMed ID: 24413822
[TBL] [Abstract][Full Text] [Related]
2. Amblyopia risk factors in congenital nasolacrimal duct obstruction: A longitudinal case-control study.
Yoo Y; Yang HK; Kim N; Choung HK; Hwang JM; Khwarg SI
PLoS One; 2019; 14(6):e0217802. PubMed ID: 31194774
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of amblyogenic factors in children with persistent congenital nasolacrimal duct obstruction.
Eshraghi B; Akbari MR; Fard MA; Shahsanaei A; Assari R; Mirmohammadsadeghi A
Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1847-52. PubMed ID: 24777709
[TBL] [Abstract][Full Text] [Related]
4. Nasolacrimal duct obstruction: Does it really increase the risk of amblyopia in children?
Ramkumar VA; Agarkar S; Mukherjee B
Indian J Ophthalmol; 2016 Jul; 64(7):496-9. PubMed ID: 27609160
[TBL] [Abstract][Full Text] [Related]
5. Amblyopia risk factors in infants with congenital nasolacrimal duct obstruction.
Kim JW; Lee H; Chang M; Park M; Lee TS; Baek S
J Craniofac Surg; 2013 Jul; 24(4):1123-5. PubMed ID: 23851753
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of amblyopia risk factors in congenital nasolacrimal duct obstruction.
Matta NS; Singman EL; Silbert DI
J AAPOS; 2010 Oct; 14(5):386-8. PubMed ID: 21035062
[TBL] [Abstract][Full Text] [Related]
7. Amblyopia Risk Factors in Newborns With Congenital Nasolacrimal Duct Obstruction.
Vagge A; Tulumello C; Pellegrini M; Di Maita M; Iester M; Traverso CE
J Pediatr Ophthalmol Strabismus; 2020 Jan; 57(1):39-43. PubMed ID: 31972039
[TBL] [Abstract][Full Text] [Related]
8. Anisometropia and Refractive Status in Children with Bilateral Congenital Nasolacrimal Duct Obstruction.
Siddiqui SN; Hannan A; Mansoor H; Asif M; Wakeel U
J Coll Physicians Surg Pak; 2018 Mar; 28(3):210-213. PubMed ID: 29544578
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of buried probe in complex congenital nasolacrimal duct obstruction and evaluation of its success rate post 'probing and irrigation': a single-centre retrospective study.
Gupta N; Chawla N; Ganesh S; Das S; Dhawan N; Bansal S; Singla P
Orbit; 2018 Dec; 37(6):397-400. PubMed ID: 29400586
[TBL] [Abstract][Full Text] [Related]
10. Success Rate of Probing for Congenital Nasolacrimal Duct Obstruction in Children.
Valcheva KP; Murgova SV; Krivoshiiska EK
Folia Med (Plovdiv); 2019 Mar; 61(1):97-103. PubMed ID: 31237856
[TBL] [Abstract][Full Text] [Related]
11. Neonatal dacryostenosis as a risk factor for anisometropia.
Piotrowski JT; Diehl NN; Mohney BG
Arch Ophthalmol; 2010 Sep; 128(9):1166-9. PubMed ID: 20837801
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Anisometropia and Refractive Status in Children With Unilateral and Bilateral Congenital Nasolacrimal Duct Obstruction.
Siddiqui SN; Mansoor H; Asif M; Wakeel U; Saleem AA
J Pediatr Ophthalmol Strabismus; 2016 May; 53(3):168-72. PubMed ID: 27224951
[TBL] [Abstract][Full Text] [Related]
13. Anisometropia and refractive status in children with congenital nasolacrimal duct obstruction-a prospective observational study.
Hareendran H; Allapitchai F; Ravindran M; Shukul K; Rengappa R
J AAPOS; 2022 Apr; 26(2):76.e1-76.e4. PubMed ID: 35314316
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the success rates of endoscopic-assisted probing in the treatment of membranous congenital nasolacrimal duct obstruction between younger and older children and its correlation with the thickness of the membrane at the Valve of Hasner.
Gupta N; Neeraj C; Smriti B; Sima D
Orbit; 2018 Aug; 37(4):257-261. PubMed ID: 29040026
[TBL] [Abstract][Full Text] [Related]
15. Results of nasolacrimal duct probing in children between 9-48 months.
Medghalchi A; Mohammadi MJ; Soltani Moghadam R; Dalili H
Acta Med Iran; 2014; 52(7):545-51. PubMed ID: 25135264
[TBL] [Abstract][Full Text] [Related]
16. Unilateral Congenital Nasolacrimal Duct Obstruction, Is It An Amblyogenic Factor?
AlHammad F; Al Tamimi E; Yassin S; AlBadri K; AlJarudi S; AlShawaf M; Khandekar R
Middle East Afr J Ophthalmol; 2018; 25(3-4):156-160. PubMed ID: 30765954
[TBL] [Abstract][Full Text] [Related]
17. Factors Predictive of Success in Probing for Congenital Nasolacrimal Duct Obstruction.
Beato J; Mota Á; Gonçalves N; Santos-Silva R; Magalhães A; Breda J; Falcão-Reis F
J Pediatr Ophthalmol Strabismus; 2017 Mar; 54(2):123-127. PubMed ID: 27977034
[TBL] [Abstract][Full Text] [Related]
18. Anisometropic amblyopia and nasolacrimal duct obstruction.
Simon JW; Ngo Y; Ahn E; Khachikian S
J Pediatr Ophthalmol Strabismus; 2009; 46(3):182-3. PubMed ID: 19496504
[TBL] [Abstract][Full Text] [Related]
19. Congenital nasolacrimal duct obstruction: common management policies among pediatric ophthalmologists.
Dotan G; Nelson LB
J Pediatr Ophthalmol Strabismus; 2015; 52(1):14-9. PubMed ID: 25365513
[TBL] [Abstract][Full Text] [Related]
20. Can congenital nasolacrimal-duct obstruction interfere with visual development? A cohort case control study.
Ellis JD; MacEwen CJ; Young JD
J Pediatr Ophthalmol Strabismus; 1998; 35(2):81-5. PubMed ID: 9559506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
